Examkin

Soru

Zorluk: ZorInfectious Diseases

A 55-year-old woman is evaluated in the hospital on day 2 of admission for uncomplicated community-acquired pneumonia. She was initially started on intravenous ceftriaxone and azithromycin. Over the past 48 hours, her temperature has normalized from an admission peak of 38.9°C (102.0°F) to 37.2°C (99.0°F), and her respiratory effort has markedly improved. Two sets of peripheral blood cultures (four bottles total) were obtained in the emergency department prior to antibiotic administration. Today, the laboratory reports that one aerobic bottle from the first set is growing Staphylococcus epidermidis. The other three bottles exhibit no growth after 48 hours of incubation. The patient has no indwelling vascular catheters or prosthetic devices. Upon receiving the culture report, the cross-covering physician immediately adds intravenous vancomycin to the patient's regimen. Which of the following is the most appropriate next step in the management of this patient's pharmacotherapy?

  1. A
    Continue vancomycin, ceftriaxone, and azithromycin for a total of 14 days
  2. B
    Discontinue ceftriaxone and azithromycin, and proceed with vancomycin monotherapy
  3. Discontinue vancomycin immediately and maintain the initial regimen for pneumoniaCevap
  4. D
    Replace vancomycin with intravenous daptomycin to target biofilm-producing organisms
  5. E
    Add oral rifampin to the current regimen to achieve synergy against the staphylococcal isolate

Cevap

Discontinue vancomycin immediately and maintain the initial regimen for pneumonia
The isolation of Staphylococcus epidermidis, a coagulase-negative staphylococcus (CoNS), in only one of four blood culture bottles strongly suggests a specimen contaminant rather than true bacteremia. CoNS are ubiquitous skin commensals. When interpreting blood cultures, growth of typical skin flora in a single bottle (from multiple sets) in a patient without prosthetic material or central venous catheters should be considered a contaminant. Furthermore, the patient is experiencing rapid clinical improvement on her initial regimen (ceftriaxone and azithromycin) for community-acquired pneumonia, which does not effectively target CoNS. Therefore, the addition of vancomycin by the cross-covering physician was inappropriate. The most correct action aligned with antimicrobial stewardship is to discontinue the unnecessary vancomycin immediately to prevent drug toxicity and resistance.

Adım Adım Çözüm

1
Analyze the blood culture results in the context of the patient's presentation.
Only one out of four blood culture bottles grew Staphylococcus epidermidis (a Coagulase-Negative Staphylococcus).
Determining the number of positive bottles is crucial for distinguishing between true bacteremia and a skin contaminant.
2
Correlate the culture findings with the patient's clinical status and risk factors.
The patient is rapidly improving on her initial pneumonia treatment and lacks indwelling hardware or catheters that would predispose her to true CoNS infection.
Clinical improvement on a regimen that does not cover the cultured organism further supports that the isolate is a contaminant.
3
Determine the appropriate antimicrobial stewardship intervention.
The addition of vancomycin was an error; it must be discontinued immediately.
Treating a contaminant exposes the patient to unnecessary drug toxicity (e.g., nephrotoxicity) and drives antimicrobial resistance.

Anahtar Kavram

Interpretation of Coagulase-Negative Staphylococci (CoNS) in blood cultures and application of antimicrobial stewardship principles
Bu soruyu puanla

Konular

Infectious Diseases

Bu konudan daha fazla soru